BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 795293)

  • 1. Prognostic significance of surface marker analysis in childhood non-Hodgkin's lymphoproliferative malifnancies.
    Coccia PF; Kersey JH; Gajil-Peczalska KJ; Krivit W; Nesbit ME
    Am J Hematol; 1976; 1(4):405-17. PubMed ID: 795293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Demonstration of immunoglobulin production by tumor cells in non-Hodgkin's and Hodgkin's malignant lymphomas and its significance for their classification.
    Stein H; Papadimitriou CS; Bouman H; Lennert K; Fuchs J
    Recent Results Cancer Res; 1978; 64():158-75. PubMed ID: 366694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum levels of CD8 antigen in childhood lymphoid malignancies: a possible indicator of increased suppressor cell activity in poor-risk patients.
    Pui CH; Ip SH; Dodge RK; Carrabis S; Brown M; Crist WM; Berard CW; Kung P; Dahl GV; Murphy SB
    Blood; 1988 Sep; 72(3):1015-21. PubMed ID: 2970871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunologic abnormalities in patients with malignant lymphoproliferative diseases.
    Hunter CP; Tannenbaum H; Churchill WH; Moloney WC; Schur PH
    J Natl Cancer Inst; 1977 May; 58(5):1185-90. PubMed ID: 323504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell surface phenotype in lymphoproliferative disease.
    Aisenberg AC; Wilkes BM; Long JC; Harris NL
    Am J Med; 1980 Feb; 68(2):206-13. PubMed ID: 6965562
    [No Abstract]   [Full Text] [Related]  

  • 6. Detection of intracellular and cell surface immunoglobulin in non-Hodgkin's lymphoma.
    Davey FR; Halliday D; Marucci AA; Gottlieb AJ
    Hum Pathol; 1978 May; 9(3):285-94. PubMed ID: 350755
    [No Abstract]   [Full Text] [Related]  

  • 7. Results of treatment of advanced-stage Burkitt's lymphoma and B cell (SIg+) acute lymphoblastic leukemia with high-dose fractionated cyclophosphamide and coordinated high-dose methotrexate and cytarabine.
    Murphy SB; Bowman WP; Abromowitch M; Mirro J; Ochs J; Rivera G; Pui CH; Fairclough D; Berard CW
    J Clin Oncol; 1986 Dec; 4(12):1732-9. PubMed ID: 3491184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The nature of childhood leukemia and lymphoma.
    Kersey JH; Gajl-Peczalska KJ; Coccia PF; Nesbit ME
    Am J Pathol; 1978 Feb; 90(2):487-95. PubMed ID: 304675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Burkitt's lymphoma presenting as acute leukemia (Burkitt's lymphoma cell leukemia): report of two cases in Israel.
    Prokocimer M; Matzner Y; Ben-Bassat H; Polliack A
    Cancer; 1980 Jun; 45(11):2884-9. PubMed ID: 6929723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute lymphoblastic leukemia with Burkitt's lymphoma cells: membrane markers and serum immunoglobulin.
    Preud'homme JL; Brouet JC; Danon F; Flandrin G; Schaison G
    J Natl Cancer Inst; 1981 Feb; 66(2):261-4. PubMed ID: 6779044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell markers in lymphoma syndrome leukemia in children: a pilot study.
    Morgan E
    Med Pediatr Oncol; 1984; 12(1):4-8. PubMed ID: 6700540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
    Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
    Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pediatric Oncology Group experience with modified LSA2-L2 therapy in 107 children with non-Hodgkin's lymphoma (Burkitt's lymphoma excluded).
    Sullivan MP; Boyett J; Pullen J; Crist W; Doering EJ; Trueworthy R; Hvizdala E; Ruymann F; Steuber CP
    Cancer; 1985 Jan; 55(2):323-36. PubMed ID: 3880656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunologic cell markers in lymphoproliferative diseases].
    Samoĭlova RS
    Ter Arkh; 1980; 52(9):140-9. PubMed ID: 7001662
    [No Abstract]   [Full Text] [Related]  

  • 15. Correlations of immunologic markers with histologic features of human non-Hodgkin's lymphomas.
    Brubaker DB; Whiteside TL; Hartsock RJ
    Am J Clin Pathol; 1979 Jun; 71(6):651-64. PubMed ID: 377943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LSA2-L2 protocol treatment of stage IV non-Hodgkin's lymphoma in children with partial and extensive bone marrow involvement.
    Duque-Hammershaimb L; Wollner N; Miller DR
    Cancer; 1983 Jul; 52(1):39-43. PubMed ID: 6573941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A morphologic study of childhood lymphoma of the undifferentiated type. The Pediatric Oncology Group experience.
    Kelly DR; Nathwani BN; Griffith RC; Shuster JJ; Sullivan MP; Hvizdala E; Murphy SB; Berard CW
    Cancer; 1987 Mar; 59(6):1132-7. PubMed ID: 3815289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surface membrane determinants on childhood acute lymphocytic leukemia cells: immunoglobulin, Fc and C3 receptors.
    Esber EC; Movassaghi N; Leikin SL
    Clin Exp Immunol; 1978 Jun; 32(3):523-30. PubMed ID: 278686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying and enumerating human T and B lymphocytes. A review of techniques, problems, and progress in clinical studies.
    Dwyer JM
    Prog Allergy; 1976; 21():178-260. PubMed ID: 794886
    [No Abstract]   [Full Text] [Related]  

  • 20. [Acute leukemia with Burkitt's lymphoma cells in two Japanese children--clinical manifestations and cell surface markers--(author's transl)].
    Kusakari A; Nakazawa S; Takane K; Yamada K
    Rinsho Ketsueki; 1981 Dec; 22(12):1962-70. PubMed ID: 6980299
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.